News – Page 605
-
News
Super-sized molecular sponges boost carbon capture
Robust zeolite remove carbon dioxide from a mix of gases at room temperature
-
News
Heaviest element claim criticised
Sighting of element 122 in piles of thorium is probably suspect, experts say
-
News
Synthesis boost for HIV research
Scarce anti-HIV plant compound made in large quantities from seed oil
-
News
Click chemistry illuminates embryo development
Synthetic sugars shipped into developing zebrafish embryo and 'clicked' with fluorescent dye
-
News
Nanoscale memristor is electronics' missing link
Titanium oxide film ends four-decade quest for basic circuit component
-
News
Chemical compass clue to migration mystery
A chemical reaction sensitive to tiny magnetic field could help to explain how birds navigate the globe
-
News
MPs berate UK government and funding agency over research cuts
Science and Technology Facilities Council is 'poorly managed', says report
-
News
International nanosafety drive launched
OECD countries put up $20m to assess fullerenes, nanotubes and cerium oxide
-
News
Cheaper nanodiamonds a boon for cancer research
Cheaper fluorescence for carbon clusters may benefit cancer imaging
-
News
Hope for Taiwan's R&D links with mainland
Research ties could grow after nationalist party victory
-
News
Stock market blow for traditional medicines
China's Traditional Chinese Medicine (TCM) industry has suffered a setback
-
News
Gene silencing gets fat
Therapies a step closer thanks to fatty nanoparticles that ferry RNAi into cells
-
Business
Business roundup: May 2008
Experts’ damning Vytorin verdict Already troubled by disappointing clinical trial results and an ongoing investigation, US drug giants Merck and Schering Plough’s combined cholesterol treatment Vytorin has now received a damning review from leading cardiologists. Source: © MERCK / SCHERING-PLOUGH PHARMACEUTICALS Trials show Vytorin’s dual action works ...